Among them, AT100 (Tau phosphorylated at Thr212-Ser214 epitope) interacts with global chromatin, progressively increases its nuclear expression with aging, and gradually disappears from the nucleus as AD progresses [17]. This evidence concerns the gene MAPT and Alzheimer disease.